ANGANY has contracted the installation of a manufacturing pilot unit in clean rooms. This will provide a capacity to manufacture clinical batches in GMP conditions for Phase I and Phase IIa studies. The production capacity of this installation could be scaled-up as required by the development of our COVID-19 products. The unit should be operational by June 2020.
